Member Info for eshaitan

Thanks.

That was a pretty strong interview. No big revelations, but at least SOH said they exceeded h1 2019 revenues already and some time ago. Of course it was only 149,000 in revenues for h1 last year, so that’s to be expected. As Holland & Barrett sales only came to fruition in January I wonder if any of that has dropped to the bottom line yet? I think Elrico guessed 90 days payment terms so it’s possible that doesn’t include H&B sales.

I would guess sweetbiotix will definitely commercialise this year if they are talking to that many companies. It can’t come soon enough in this market. Top up tomorrow.

To think less than 2 months ago we could have sold at really 3 times this price!

As distressing it is to see my portfolio take a beating it really is an eye opener watching the world and markets overreact. It’s completely self inflicted pain which will hopefully ease in the next couple of months.

Optibiotix isn’t going bust. It’s too diverse and the overheads are too low. It doesn’t need to raise equity. At worst any new deals might not be signed if air travel is restricted for a while but there are plenty coming to fruition.

Oh it's definitely overdone, I'm topping up again Thursday. Noone wants to seem to buy these shares or can't at the moment. It will snap back, it's just a question of when.

Unfortunately not.

It will be interesting what happens today it looks like another blood bath on the markets.

Another top up next Thursday I think.

Is that anything that evens up H1 and h2 revenues has to be a good thing. I’m glad the deal has been extended with SACCO they have done great work, especially with that dairy announcement in Uruguay.

The world will come to its senses soon.

More people die worldwide daily from automobile accidents than have died so far from covid19. Shame it’s takes the old and I’ll instead of the stupid that panic buy toilet paper....

https://www.nutraceuticalbusinessreview.com/news/article_page/OptiBiotix_meets_with_Australia_partner_to_continue_SlimBiome_growth/163030

One to keep an eye on.

The figures for slimbiome make sense, and it’s right to err on the side of caution, but it could be much more. I wonder if Holland and Barrett will even up h1 and H2 revenues even more?

I see optibiotix we’re visiting maxum foods in Australia this week. Their head office is in Brisbane where I now live and their manufacturing is in Victoria. Hopefully something comes from that soon, I think it would do well here as well.

I have seen 2 companies selling cholbiome in Spain online as well under their own brand names. 39ytu sell it under the name Coles Pro 39ytu another company sell it as stop&go cholesterol.

The Latvian distributor is live as well. Biolat sell it as AngioPro, I think they are distributing to 3 countries.

Looking at the reviews it’s an amazingly effective product, I’m glad it working for you as well. I still wish they would sell it through a large company like Holland and Barrett. I’m sure they could do more in the UK market, at the moment it seems like word of mouth is the biggest medium to advertise it.

There are so many stocks out there that look cheap. But I can’t see opti being affected too much by this, so I’m happy to average down.

One more top up today and then I’m averaging 50p which I think is not too bad. I didn’t expect to see these levels again but there you go, one sick bat and the world melts down.

I wouldn’t worry too much it’s just one of those market sell offs that has affected all indices, it’s not really the boards fault.

I invested for lpldl not slimbiome, although the latter is doing amazingly well. Just going online I could see capsule products with lpldl for sale in the uk, Germany, Italy,New Zealand, and USA (seed). I have no doubt they will enter into the other territories they signed distribution agreements for as well, making cholbiome capsules (or whatever name they sell under locally) available in 20 plus countries. India supposedly has gone live as well but I can’t find their products yet.

But I didn’t invest for the cholbiome capsules either as it’s a niche product, I invested because I thought lpldl would go into high volume food products. There has been agreements signed in Spain, Italy and Uruguay to do just that so far and may happen in other territories like India soon but going through the rns timeline it looks like the next big news for lpldl will be America. There has been a lot of progress there in a relatively short space of time.

Had to be done, this drop is madness.

It should be fine within the next 6 months when fundamentals kick in and the company states it is profitable.

It’s a joke that Goetz are still forecasting worldwide sales of slimbiome of just 1 million for 2020. I expect a Goetz upgrade at the same time and a year end share price in excess of 80p.

Not sure if it warranted an rns. But their strategy seems sensible. With very high margins even after discounting it makes sense to lock people into recurring supplies.

I noticed quite a few people complaining about the size of the cholbiome tablets on reviews so it’s good they are taking that on board. Especially with them being rolled out in multiple territories.

The expansion of optibiotix’s range is also interesting. But what I really am looking forward to is the next trading update with solid numbers.

From TW on his website this morning. I won’t break his copyright but it’s very bullish and well worth a read.

This is looking very cheap.

You will own shares in an unlisted company. You get nothing.

Uruguayan yoghurts today, tomorrow the stars. Or something like that...

It said that on their website in December.

But where exactly? I can’t find any online.

I think this was announced in December.

I haven’t managed to find any pharmacies online selling meta lite or meta lite pro yet. Or on metalites homepage, where the purchase link doesn’t work.

Unlike ezimega3 in Italy which is advertised on about 20 online pharmacies.